Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.13 USD | -3.74% | -5.47% | -18.19% |
09/05 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05/04 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.19% | 623M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- Kanghua Biological Products Licenses Norovirus Vaccine to HilleVax